wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38525073-DE960FCF-7BDA-4D0E-9372-8A19367EF830
Q38525073-DE960FCF-7BDA-4D0E-9372-8A19367EF830
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38525073-DE960FCF-7BDA-4D0E-9372-8A19367EF830
An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancer.
P2860
Q38525073-DE960FCF-7BDA-4D0E-9372-8A19367EF830
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38525073-DE960FCF-7BDA-4D0E-9372-8A19367EF830
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cecb4aa7dee6a5c9309ad7ff25a16819bcf5a488
P2860
A phase I dose-escalation study of danusertib (PHA-739358) administered as a 24-hour infusion with and without granulocyte colony-stimulating factor in a 14-day cycle in patients with advanced solid tumors.